Assessment of the long‐term efficacy and safety of adjunctive perampanel in tonic‐clonic seizures: Analysis of four open‐label extension studies-Reference-Cited by-同舟云学术

Assessment of the long‐term efficacy and safety of adjunctive perampanel in tonic‐clonic seizures: Analysis of four open‐label extension studies

Published:2020-07 Issue:7 Volume:61 Page:1491-1502
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Rektor Ivan¹^ORCID,Krauss Gregory L.²^ORCID,Inoue Yushi³,Kaneko Sunao⁴,Williams Betsy⁵,Patten Anna⁶,Malhotra Manoj⁷,Laurenza Antonio⁵,Wechsler Robert T.⁸^ORCID

Affiliation:

1. Brno Epilepsy Center and Central European Institute of Technology (CEITEC) Masaryk University Brno Czech Republic

2. Department of Neurology Johns Hopkins University School of Medicine Baltimore Maryland USA

3. National Epilepsy Center Shizuoka Institute of Epilepsy and Neurological Disorders Shizuoka Japan

4. North Tohoku Epilepsy Center Minato Hospital Hachinohe Japan

5. Formerly: Eisai Inc. Woodcliff Lake New Jersey USA

6. Eisai Ltd. Hatfield UK

7. Eisai Inc. Woodcliff Lake New Jersey USA

8. Idaho Comprehensive Epilepsy Center Boise Idaho USA

Funder

Eisai Inc.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.16573

Reference37 articles.

1. Food and Drug Administration.Fycompa® prescribing information. May 2019. Available at:https://www.fycompa.com/‐/media/Files/Fycompa/Fycompa_Prescribing_Information.pdf. Accessed May 11 2020.

2. European Medicines Agency.Fycompa® annex I: summary of product characteristics. April 2017. Available at:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_‐_Product_Information/human/002434/WC500130815.pdf. Accessed May 11 2020.

3. Tolerability and safety of perampanel: two randomized dose-escalation studies

4. Adjunctive perampanel for refractory partial-onset seizures: Randomized phase III study 304

5. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of adjunctive perampanel treatment in pediatric patients with epilepsy aged 4–12 years: a real-world study;Journal of Neurology;2024-05-08

2. Long‐term efficacy and safety of adjunctive perampanel in patients from the Asia‐Pacific region with refractory focal‐onset seizures in Study 335 open‐label extension;Epilepsia Open;2024-01-06

3. Perampanel-induced erectile dysfunction;Neurological Sciences;2023-11-30

4. Efficacy and safety of perampanel monotherapy in Chinese patients with focal‐onset seizures: A single‐center, prospective, real‐world observational study;Epilepsia Open;2023-09-25

5. Efficacy and safety of perampanel as early add-on therapy in Chinese patients with focal-onset seizures: a multicenter, open-label, single-arm study;Frontiers in Neurology;2023-08-30